XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

STOXX 600 recovers early losses on US jobs data relief



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-STOXX 600 recovers early losses on US jobs data relief</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

Novo rebounds on positive read-across from Lilly

Siemens jumps after profit beat

Allianz rises on Q2 beat

Deutsche Telekom up after increase in Q2 core earnings

STOXX 600 up 0.1%

Updates at 1600 GMT

By Ankika Biswas and Pranav Kashyap

Aug 8 (Reuters) -Europe's benchmark stock index recouped early losses to close slightly higher on Thursday, helped by encouraging U.S. jobs market data and as the heavy-weight healthcare sector got a boost from Novo Nordisk's recovery.

The STOXX 600 .STOXX closed 0.1% higher, after a sharp early decline in technology stocks knocked the pan-European index down over 1% intraday.

Data showed weekly U.S. jobless claims fell more than expected, suggesting fears of a sharp weakening in the labour market, which in part had fuelled U.S. recession fears, were overblown.

"Just because the labour market is cooling off doesn't mean we're (U.S.) entering into a recession. While there has been renewed worry about the labour market, we believe it's overblown," said from Skyler Weinand, chief investment officer, Regan Capital.

As European stocks recovered after the data, Wall Street also enjoyed strong gains for the day.

The STOXX 600 has been volatile this week as investors evaluated fears of a potential U.S. recession and looked for clear macroeconomic signals, both at home and globally.

German inflation data, due on Friday, will give investors a clearer picture on Europe's largest economy as it teeters on the verge of a recession.

Europe's largest company by market value, Novo Nordisk NOVOb.CO, rose 4.3%, recovering more than half of Wednesday's near 7% slide, as rival Eli Lilly's LLY.N raised its annual sales forecast, boding well for the Danish drug maker.

Healthcare .SXDP was among the top sectoral gainers, also boosted by a 8.3% jump in British drugmaker Hikma Pharmaceuticals HIK.L on an upbeat annual outlook, while media .SXMP was the worst hit sector.

Allianz ALVG.DE gained 2% after the German insurer posted a better-than-expected rise in second-quarter net profit and said it was on track to meet its full-year target.

Several other European insurers recorded bumper first-half profits on Thursday, such as Zurich Insurance ZURN.S, Munich Re MUVGn.DE and London's Beazley BEZG.L.

Siemens SIEGn.DE rose 2.1% after beating quarterly earnings forecasts.

Deutsche Telekom DTEGn.DE was up 1.9% after the telecom firm reported a 7.8% increase in its second-quarter core earnings, while Entain ENT.L climbed 5% as the British gambling group raised its annual revenue forecast.

Meanwhile, valve maker Spirax-Sarco Engineering SPX.L dropped 7.4% after results, while German sportswear maker Puma PUMG.DE fell 4% as a raft of brokerage price-target cuts followed Wednesday's dismal earnings.



Reporting by Pranav Kashyap and Ankika Biswas in Bengaluru; Editing by Sonia Cheema, Varun H K and Christina Fincher

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.